Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 3

September 23, 2021

Listen to key experts from a multidisciplinary team discuss how patients with endometrial cancer should be tested to determine suitability for PD-1/PD-L1 inhibitor therapy.

The multidisciplinary team

  • Gynaecological oncologist: Prof. Nicole Concin
  • Pathologist: Dr Alicia León-Castillo

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from GlaxoSmithKline. This medical education is provided by touchIME.


For further information visit:

Podbean App

Play this podcast on Podbean App